UniPharma Balance Sheet Health
Financial Health criteria checks 6/6
UniPharma has a total shareholder equity of NT$312.7M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$350.1M and NT$37.4M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | n/a |
Cash | NT$174.18m |
Equity | NT$312.67m |
Total liabilities | NT$37.40m |
Total assets | NT$350.07m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6621's short term assets (NT$226.2M) exceed its short term liabilities (NT$37.1M).
Long Term Liabilities: 6621's short term assets (NT$226.2M) exceed its long term liabilities (NT$285.0K).
Debt to Equity History and Analysis
Debt Level: 6621 is debt free.
Reducing Debt: 6621 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 6621 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 6621 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 30.4% per year.